Joshua T. Brumm, Chief Executive Officer at CRESCENT BIOPHARMA, INC. (CBIO), sold 9,447 shares at $17.90 ($160K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($160k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 1,610 | $29K | 18.0% |
| 2 | $16.71 | 7,837 | $131K | 82.0% |
| Total | $16.91 avg | 9,447 | $160K | 100% |
| Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |
| DYN | SELL | 2024-01-04 | $9.7M | — | Filing → |